Growblox Sciences Inc (GBLX) 0.3652 $GBLX
GrowBLOX Sciences Announces Patent Filings for Its Proprietary Process to Create Uniform Reproducible Cannabis Extracts
ACCESSWIRE - Tue Oct 13, 8:01AM CDT
GBLX Staying at the Forefront of Medical Cannabis Technology
GrowBLOX Sciences Announces First of Four Cultivation Labs Scheduled to Open in Las Vegas
ACCESSWIRE - Mon Sep 28, 8:02AM CDT
Expected to Open by End of Fourth Quarter; $10-12 Million Annual Revenue at Full Capacity at Just This Facility; Cutting-Edge Technological Growing of Medical Grade Cannabis
Cannabis Companies Hunt for Financing, Growth
at The Street - Fri Sep 25, 9:51AM CDT
Companies in the cannabis business have an appetite for capital to fuel what has emerged as one of the largest growth sectors, and more investors are taking the risk.
XXII: 1.19 (-0.06), FB: 97.54 (+1.58), PYPL: 34.29 (-0.33), ARNA: 2.31 (-0.09)
GrowBLOX Sciences Secures Four New Nevada State Medical Cannabis Licenses
ACCESSWIRE - Wed Sep 16, 8:01AM CDT
Continues to Accelerate its Plans for Significant Revenue Growth in 2016
GrowBLOX Sciences Appoints Former Nevada State Senator Sandra Tiffany as New General Manager
ACCESSWIRE - Tue Sep 08, 8:01AM CDT
Continues the Development of a Formidable GBLX Executive Team
GrowBLOX Sciences Appoints New CFO John Poss
ACCESSWIRE - Tue Aug 25, 7:30AM CDT
Creating a Formidable Executive Team
GrowBLOX Sciences is Making Big Moves in Anticipation of Opening Nevada Cultivation Facility
GlobeNewswire - Thu Jul 23, 1:17PM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced that over the course of the next few weeks certain changes in management personnel and operating procedures would soon be implemented in preparation for the commencement of cultivation operations through our majority-owned subsidiary, GB Sciences Nevada, LLC.
DigiPath (DIGP) Well Positioned to Take Advantage of $850M Cannabis Testing Market
ACCESSWIRE - Thu Jul 16, 8:00AM CDT
WHITEFISH, MT / ACCESSWIRE / July 16, 2015 / There are many different ways to profit from the burgeoning cannabis industry, ranging from GrowBLOX Sciences Inc.'s (OTCQB: GBLX) growing solutions to Medbox Inc.'s (OTCQB: MDBX) dispensing technologies to Cannabis Science Inc.'s (OTCQB: CBIS) focus on the medicinal properties of the plant, but cannabis testing could be the most compelling.
These Cannabis Stocks Are Heating Up This Summer, 2015
ACCESSWIRE - Tue Jun 16, 3:07PM CDT
CORAL GABLES, FL / ACCESSWIRE / June 16, 2015 / More states are jumping on board the cannabis train and this industry has certainly begun to evolve since Colorado first came online as America's original legal state. Despite the recent uproar concerning the decision for business owners not to condone cannabis use (medical or otherwise), the market continues to take a liking to this industry because it is, in fact, just beginning to blossom. Aside from popular belief, this space isn't full of growers alone, there is an entire economy growing around the idea. Businesses are sprouting up with ideas from anything like cannabis vacation destinations to hemp infused beverages and anything in between. Companies like FBEC Worldwide (PINKSHEETS: FBEC), the Maryjane Group (OTCQB: MJMJ) and GrowBLOX Sciences, Inc. (OTCQB: GBLX) have all begun to see interest building around their novel concepts.
GrowBLOX Receives Funding to Complete Construction of Nevada Cultivation Facility
GlobeNewswire - Mon Jun 15, 10:51AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced here today that it has received a $1.75 million funding commitment to enable GrowBLOX to complete construction and set-up operations at their MME Cultivation Facility in Las Vegas, Nevada. Pacific Leaf Ventures, LP has provided both the capital infusion and a license for their intellectual property including recognizable brand-names of cannabis and proprietary know-how for cultivation and cannabis extractions.
GrowBLOX Announces Deployment of Commercial Units
GlobeNewswire - Tue May 26, 12:29PM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the receipt of production-model GrowBLOX(TM) units for both GB Sciences Nevada (GBSN) and GB Sciences Puerto Rico (GBS PR).
GROWBlox Sciences Takes Integrated Approach to Cannabis Medicine
ACCESSWIRE - Mon May 25, 7:36PM CDT
Untitled Document
GWPH: 90.71 (+3.03), GNC: 40.75 (+0.05), DGX: 65.36 (+1.29), NUTR: 23.70 (-0.01), LH: 117.41 (+2.03)
Growblox Announces Commercialization Initiative and Financing
GlobeNewswire - Wed May 13, 7:00AM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today it has established Growblox Sciences Puerto Rico, LLC ("GBS PR"
, a majority-owned subsidiary domiciled in Puerto Rico.
Growblox Sciences Announces Launch of New Corporate Website
GlobeNewswire - Mon May 11, 11:21AM CDT
Growblox Sciences Inc. (OTCQB:GBLX) ("Growblox" or the "Company", a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the launch of its new corporate website.
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part IV
Anthony Cataldo - at Seeking Alpha - Fri Apr 17, 12:54PM CDT
FULL: 3.17 (+0.02), GWPH: 90.71 (+3.03)
Building A 'Risk-Adverse' Pot Stock Portfolio
Matthew Finston - at Seeking Alpha - Mon Mar 09, 12:06AM CDT
Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 26.25 (+0.34), FULL: 3.17 (+0.02), CARA: 14.56 (-0.07)
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 90.71 (+3.03), FULL: 3.17 (+0.02), CARA: 14.56 (-0.07)
GrowBLOX Signs License Agreement Including Initial Royalty Payment of $300,000 on its New Technology for the Consistent Production of Medical Cannabis
ACCESSWIRE - Wed Feb 04, 7:53AM CST
Las Vegas, NV / ACCESSWIRE / February 4, 2015 / GrowBLOX Sciences, Inc., "GB Sciences" (GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation, which are designed to produce consistent medicinal cannabis, has signed an agreement to license certain of its proprietary TissueBLOX technology to an unaffiliated licensed cannabis testing company. The licensed technology consists of certain equipment, procedures, and know-how related to the seedless propagation of genetically-identified strains of cannabis. The technology will enable the licensee to offer as a service to third-party growers the ability to grow specific strains of cannabis with an unprecedented level of reliability, precision, and most importantly, consistency of genetic material. As a practical matter what this means is that any grower, having developed and tested a strain of cannabis with certain characteristics desired by the grower, can provide for the continuous and consistent production of the genetics for that strain, enabling it to be branded as either a recreational or medicinal product.
GrowBLOX Sciences Announces Patent Filings for Its Proprietary Process to Create Uniform Reproducible Cannabis Extracts
ACCESSWIRE - Tue Oct 13, 8:01AM CDT
GBLX Staying at the Forefront of Medical Cannabis Technology
GrowBLOX Sciences Announces First of Four Cultivation Labs Scheduled to Open in Las Vegas
ACCESSWIRE - Mon Sep 28, 8:02AM CDT
Expected to Open by End of Fourth Quarter; $10-12 Million Annual Revenue at Full Capacity at Just This Facility; Cutting-Edge Technological Growing of Medical Grade Cannabis
Cannabis Companies Hunt for Financing, Growth
at The Street - Fri Sep 25, 9:51AM CDT
Companies in the cannabis business have an appetite for capital to fuel what has emerged as one of the largest growth sectors, and more investors are taking the risk.
XXII: 1.19 (-0.06), FB: 97.54 (+1.58), PYPL: 34.29 (-0.33), ARNA: 2.31 (-0.09)
GrowBLOX Sciences Secures Four New Nevada State Medical Cannabis Licenses
ACCESSWIRE - Wed Sep 16, 8:01AM CDT
Continues to Accelerate its Plans for Significant Revenue Growth in 2016
GrowBLOX Sciences Appoints Former Nevada State Senator Sandra Tiffany as New General Manager
ACCESSWIRE - Tue Sep 08, 8:01AM CDT
Continues the Development of a Formidable GBLX Executive Team
GrowBLOX Sciences Appoints New CFO John Poss
ACCESSWIRE - Tue Aug 25, 7:30AM CDT
Creating a Formidable Executive Team
GrowBLOX Sciences is Making Big Moves in Anticipation of Opening Nevada Cultivation Facility
GlobeNewswire - Thu Jul 23, 1:17PM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced that over the course of the next few weeks certain changes in management personnel and operating procedures would soon be implemented in preparation for the commencement of cultivation operations through our majority-owned subsidiary, GB Sciences Nevada, LLC.
DigiPath (DIGP) Well Positioned to Take Advantage of $850M Cannabis Testing Market
ACCESSWIRE - Thu Jul 16, 8:00AM CDT
WHITEFISH, MT / ACCESSWIRE / July 16, 2015 / There are many different ways to profit from the burgeoning cannabis industry, ranging from GrowBLOX Sciences Inc.'s (OTCQB: GBLX) growing solutions to Medbox Inc.'s (OTCQB: MDBX) dispensing technologies to Cannabis Science Inc.'s (OTCQB: CBIS) focus on the medicinal properties of the plant, but cannabis testing could be the most compelling.
These Cannabis Stocks Are Heating Up This Summer, 2015
ACCESSWIRE - Tue Jun 16, 3:07PM CDT
CORAL GABLES, FL / ACCESSWIRE / June 16, 2015 / More states are jumping on board the cannabis train and this industry has certainly begun to evolve since Colorado first came online as America's original legal state. Despite the recent uproar concerning the decision for business owners not to condone cannabis use (medical or otherwise), the market continues to take a liking to this industry because it is, in fact, just beginning to blossom. Aside from popular belief, this space isn't full of growers alone, there is an entire economy growing around the idea. Businesses are sprouting up with ideas from anything like cannabis vacation destinations to hemp infused beverages and anything in between. Companies like FBEC Worldwide (PINKSHEETS: FBEC), the Maryjane Group (OTCQB: MJMJ) and GrowBLOX Sciences, Inc. (OTCQB: GBLX) have all begun to see interest building around their novel concepts.
GrowBLOX Receives Funding to Complete Construction of Nevada Cultivation Facility
GlobeNewswire - Mon Jun 15, 10:51AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced here today that it has received a $1.75 million funding commitment to enable GrowBLOX to complete construction and set-up operations at their MME Cultivation Facility in Las Vegas, Nevada. Pacific Leaf Ventures, LP has provided both the capital infusion and a license for their intellectual property including recognizable brand-names of cannabis and proprietary know-how for cultivation and cannabis extractions.
GrowBLOX Announces Deployment of Commercial Units
GlobeNewswire - Tue May 26, 12:29PM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the receipt of production-model GrowBLOX(TM) units for both GB Sciences Nevada (GBSN) and GB Sciences Puerto Rico (GBS PR).
GROWBlox Sciences Takes Integrated Approach to Cannabis Medicine
ACCESSWIRE - Mon May 25, 7:36PM CDT
Untitled Document
GWPH: 90.71 (+3.03), GNC: 40.75 (+0.05), DGX: 65.36 (+1.29), NUTR: 23.70 (-0.01), LH: 117.41 (+2.03)
Growblox Announces Commercialization Initiative and Financing
GlobeNewswire - Wed May 13, 7:00AM CDT
Growblox Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today it has established Growblox Sciences Puerto Rico, LLC ("GBS PR"
, a majority-owned subsidiary domiciled in Puerto Rico. Growblox Sciences Announces Launch of New Corporate Website
GlobeNewswire - Mon May 11, 11:21AM CDT
Growblox Sciences Inc. (OTCQB:GBLX) ("Growblox" or the "Company"
, a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the launch of its new corporate website. Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part IV
Anthony Cataldo - at Seeking Alpha - Fri Apr 17, 12:54PM CDT
FULL: 3.17 (+0.02), GWPH: 90.71 (+3.03)
Building A 'Risk-Adverse' Pot Stock Portfolio
Matthew Finston - at Seeking Alpha - Mon Mar 09, 12:06AM CDT
Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 26.25 (+0.34), FULL: 3.17 (+0.02), CARA: 14.56 (-0.07)
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 90.71 (+3.03), FULL: 3.17 (+0.02), CARA: 14.56 (-0.07)
GrowBLOX Signs License Agreement Including Initial Royalty Payment of $300,000 on its New Technology for the Consistent Production of Medical Cannabis
ACCESSWIRE - Wed Feb 04, 7:53AM CST
Las Vegas, NV / ACCESSWIRE / February 4, 2015 / GrowBLOX Sciences, Inc., "GB Sciences" (GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation, which are designed to produce consistent medicinal cannabis, has signed an agreement to license certain of its proprietary TissueBLOX technology to an unaffiliated licensed cannabis testing company. The licensed technology consists of certain equipment, procedures, and know-how related to the seedless propagation of genetically-identified strains of cannabis. The technology will enable the licensee to offer as a service to third-party growers the ability to grow specific strains of cannabis with an unprecedented level of reliability, precision, and most importantly, consistency of genetic material. As a practical matter what this means is that any grower, having developed and tested a strain of cannabis with certain characteristics desired by the grower, can provide for the continuous and consistent production of the genetics for that strain, enabling it to be branded as either a recreational or medicinal product.
